TreeNumberList
Element Information
Model
Used By
| Element | DescriptorRecord |
Source
<xs:element name="TreeNumberList"> <xs:complexType> <xs:sequence> <xs:element maxOccurs="unbounded" ref="TreeNumber"/> </xs:sequence> </xs:complexType> </xs:element> |
Sample
|
D000001 |
|
Calcimycin |
|
1974 |
|
11 |
|
19 |
|
2016 |
|
05 |
|
27 |
|
1984 |
|
01 |
|
01 |
|
Q000031 |
|
analogs & derivatives |
|
AA |
|
Q000276 |
|
immunology |
|
IM |
|
Q000493 |
|
pharmacokinetics |
|
PK |
|
Q000096 |
|
biosynthesis |
|
BI |
|
Q000627 |
|
therapeutic use |
|
TU |
|
Q000633 |
|
toxicity |
|
TO |
|
Q000506 |
|
poisoning |
|
PO |
|
Q000008 |
|
administration & dosage |
|
AD |
|
Q000009 |
|
adverse effects |
|
AE |
|
Q000819 |
|
agonists |
|
AG |
|
Q000097 |
|
blood |
|
BL |
|
Q000134 |
|
cerebrospinal fluid |
|
CF |
|
Q000138 |
|
chemical synthesis |
|
CS |
|
Q000744 |
|
contraindications |
|
CT |
|
Q000737 |
|
chemistry |
|
CH |
|
Q000652 |
|
urine |
|
UR |
|
Q000528 |
|
radiation effects |
|
RE |
|
Q000266 |
|
history |
|
HI |
|
Q000032 |
|
analysis |
|
AN |
|
Q000037 |
|
antagonists & inhibitors |
|
AI |
|
Q000145 |
|
classification |
|
CL |
|
Q000191 |
|
economics |
|
EC |
|
Q000302 |
|
isolation & purification |
|
IP |
|
Q000378 |
|
metabolism |
|
ME |
|
Q000494 |
|
pharmacology |
|
PD |
|
Q000592 |
|
standards |
|
ST |
|
Q000600 |
|
supply & distribution |
|
SD |
|
91(75); was A 23187 1975-90 (see under ANTIBIOTICS 1975-83) |
|
use CALCIMYCIN to search A 23187 1975-90 |
|
91; was A 23187 1975-90 (see under ANTIBIOTICS 1975-83) |
|
Antibiotics (1973-1974) |
|
Carboxylic Acids (1973-1974) |
|
D000900 |
|
Anti-Bacterial Agents |
|
D061207 |
|
Calcium Ionophores |
|
D03.633.100.221.173 |
|
M0000001 |
|
Calcimycin |
|
4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))- |
|
37H9VM9WZL |
|
An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. |
|
52665-69-7 (Calcimycin) |
|
M0000001 |
|
M0353609 |
|
T000002 |
|
Calcimycin |
|
1999 |
|
01 |
|
01 |
|
FDA SRS (2014) |
|
NLM (1975) |
|
M0353609 |
|
A-23187 |
|
0 |
|
M0000001 |
|
M0353609 |
|
T000001 |
|
A-23187 |
|
1990 |
|
03 |
|
08 |
|
NLM (1991) |
|
T000001 |
|
A 23187 |
|
T000004 |
|
A23187 |
|
1974 |
|
11 |
|
11 |
|
UNK (19XX) |
|
T000003 |
|
Antibiotic A23187 |
|
1990 |
|
03 |
|
08 |
|
NLM (1991) |
|
T000003 |
|
A23187, Antibiotic |